{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T11:01:07Z","timestamp":1648983667033},"reference-count":29,"publisher":"Georg Thieme Verlag KG","issue":"05","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dtsch Med Wochenschr"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1055\/a-1235-0533","type":"journal-article","created":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T23:36:49Z","timestamp":1614641809000},"page":"317-322","source":"Crossref","is-referenced-by-count":0,"title":["Die Niere als Schrittmacher kardiovaskul\u00e4rer Alterung"],"prefix":"10.1055","volume":"146","author":[{"given":"Christoph","family":"Wanner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Galle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Lopau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2021,3,1]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.kint.2017.01.030","article-title":"Diabetes with early kidney involvement may shorten life expectancy by 16 years","volume":"92","author":"C P Wen","year":"2017","journal-title":"Kidney Int"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.atherosclerosis.2015.08.020","article-title":"Association of relative telomere lengths with cardiovascular disease in a large chronic kidney disease cohort: the GCKD study","volume":"242","author":"J Raschenberger","year":"2015","journal-title":"Atherosclerosis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/joim.13242","article-title":"GCKD Investigators","author":"F Fazzini","year":"2021","journal-title":"J\u00a0Intern Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1093\/ndt\/gfz174","article-title":"A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases","volume":"34","author":"K J Jager","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1093\/ndt\/4.10.859","article-title":"Similar risks of nephropathy in patients with type 1 or type 2 diabetes mellitus","volume":"4","author":"C Hasslacher","year":"1989","journal-title":"Nephrol Dial Transplant"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.kint.2020.06.024","article-title":"Executive summary of\u00a0the 2020 KDIGO Diabetes Management in CKD Guideline: evidence-based advances in monitoring and treatment","volume":"98","author":"I H de Boer","year":"2020","journal-title":"Kidney Int"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.2215\/CJN.11491116","article-title":"Diabetic kidney disease: challenges, progress, and possibilities","volume":"12","author":"R Z Zlicic","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/eurheartj\/ehz486","article-title":"ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD","volume":"41","author":"F Cosentino","year":"2020","journal-title":"Eur Heart J"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa043545","article-title":"Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis","volume":"353","author":"C Wanner","year":"2005","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1038\/ki.2015.246","article-title":"Implementation of the KDIGO guideline on lipid management requires a substantial increase in statin prescription rates","volume":"88","author":"M P Schneider","year":"2015","journal-title":"Kidney Int"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1056\/NEJMcibr1608564","article-title":"Nephron protection in diabetic kidney disease","volume":"375","author":"H J Anders","year":"2016","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.kint.2016.02.043","article-title":"Challenging the dogma of mitochondrial reactive oxygen species overproduction in diabetic kidney disease","volume":"90","author":"M T Coughlan","year":"2016","journal-title":"Kidney Int"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1172\/JCI72271","article-title":"Molecular mechanism of diabetic kidney disease","volume":"124","author":"K Reidy","year":"2014","journal-title":"J Clin Invest"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1093\/ndt\/gfz230","article-title":"Renal physiology of glucose handling and therapeutic implications","volume":"35","author":"D Z Cherney","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41581-020-00350-x","article-title":"Organ protection by SGLT2 inhibitors: role of metabolic energy and water conservation","volume":"17","author":"A Marton","year":"2021","journal-title":"Nat Rev Nephrol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00125-016-4157-3","article-title":"Targeting renal glucose reabsorption to treat hyperglycaemia: the pleiotropic effects of SGLT2 inhibition","volume":"60","author":"V Vallon","year":"2017","journal-title":"Diabetologia"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction","volume":"381","author":"J JV McMurray","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes","volume":"373","author":"B Zinman","year":"2015","journal-title":"N Engl J Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure","volume":"383","author":"M Packer","year":"2020","journal-title":"N Engl J Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.052186","article-title":"Effect of Empagliflozin on Left Ventricular Volumes in Patients with Type 2 Diabetes, or Prediabetes, and Heart Failure with Reduced Ejection Fraction (SUGAR-DM-HF)","author":"M MY Lee","year":"2020","journal-title":"Circulation"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy","volume":"345","author":"B M Brenner","year":"2001","journal-title":"N Engl J Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy","volume":"380","author":"V Perkovic","year":"2019","journal-title":"N Engl J Med"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes","volume":"383","author":"G L Bakris","year":"2020","journal-title":"N Engl J Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1016\/S0140-6736(19)30772-X","article-title":"Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial","volume":"393","author":"H JL Heerspink","year":"2019","journal-title":"Lancet"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1056\/NEJMoa1915928","article-title":"Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction","volume":"382","author":"P W Armstrong","year":"2020","journal-title":"N Engl J Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.052926","article-title":"How should we sequence the treatments for heart faIlure and a reduced ejection fraction? A redefinition of evidencE-based Medicine","author":"J JV McMurray","year":"2020","journal-title":"Circulation"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"e1918169","DOI":"10.1001\/jamanetworkopen.2019.18169","article-title":"Clinical Characteristics of and Risk Factors for Chronic Kidney Disease Among Adults and Children: An analysis of the CURE-CKD Registry","volume":"2","author":"K R Tuttle","year":"2019","journal-title":"JAMA Netw Open"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1056\/NEJMoa1515920","article-title":"Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes","volume":"375","author":"C Wanner","year":"2016","journal-title":"N Engl J Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in Patients with Chronic Kidney Disease","volume":"383","author":"H JL Heerspink","year":"2020","journal-title":"N Engl J Med"}],"container-title":["DMW - Deutsche Medizinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-1235-0533.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T23:37:53Z","timestamp":1614641873000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-1235-0533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":29,"journal-issue":{"issue":"05","published-online":{"date-parts":[[2021,3,1]]},"published-print":{"date-parts":[[2021,3]]}},"URL":"https:\/\/doi.org\/10.1055\/a-1235-0533","relation":{},"ISSN":["0012-0472","1439-4413"],"issn-type":[{"value":"0012-0472","type":"print"},{"value":"1439-4413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3]]}}}